Abhishek Jain: New Microphysiological Model Sheds Light on COVID-19 Vascular Complications
Abhishek Jain, Associate Professor of Biomedical Engineering, Medical Physiology and Cardiovascular Sciences at Texas A and M University College of Engineering, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Haemostasis, adding:
“Can microphysiological systems (MPS) be used in high containment environments to model serious infection-induced blood clots?
Our new work, with first author being my grad student Sreelakshmy Suresh, supported by UG scholar Rebecca John in Texas A and M University Department of Biomedical Engineering, is now published in International Society on Thrombosis and Haemostasis (ISTH) Journal of Thrombosis and Haemostasis (JTH).
We use a simple-to-deploy human vessel-chip to uncover the ‘shear–cytokine crosstalk’ driving SARS-CoV-2 endotheliopathy.
Our collaborators include John Cooke at Houston Methodist and John Connor at Boston University School of Medicine.
We found that under both passive and the living virus exposure, while physiological blood flow (laminar shear stress) provides a ‘structural shield’ for our blood vessels, high levels of cytokine IL-6 can override this protection — fueling viral replication and creating a high-risk environment for thrombosis.
This research provides an easily tunable platform to test antivirals and therapies aimed at stabilizing the endothelium and preventing microthrombi.”
Title: Shear cytokine crosstalk is a determinant of SARS-CoV-2–induced endothelial pathophysiology and thrombosis in human vessel chips
Authors: Sreelakshmy Suresh, Rebecca John, John P. Cooke, John H. Connor, Abhishek Jain
Proceed to the video attached to the post.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 14:07Satyadeep Dash: Why Calcium Is Critical to Effective Hemostasis
-
Jun 3, 2026, 13:51Ton Lisman: ISTH Opens Applications for Leadership Roles in Liver Disease Research
-
Jun 3, 2026, 13:26M Shujat Rasool: DVT Red Flags Every Clinician Should Know
-
Jun 3, 2026, 09:14Wolfgang Miesbach: How Should We Monitor FVIII Expression After AAV5-Based Gene Therapy?
-
Jun 3, 2026, 09:02June Giddings: Giddings Strong Foundation Website Is Now Live
-
Jun 3, 2026, 08:47Alba Grayston Morales: How IL-1 Signaling Drives Injury and Repair in The Ischaemic Brain
-
Jun 3, 2026, 08:32Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
-
Jun 3, 2026, 08:27Leonard Valentino: Why Clear Communication Matters in the Era of Gene Editing
-
Jun 3, 2026, 08:15Wolfgang Miesbach: When to Stop Anticoagulation after AF Ablation in 2026?